Analysts Endorse Ranbaxy-Pfizer Deal On Lipitor

MUMBAI - Analysts have backed the settlement deal between Ranbaxy Laboratories and Pfizer on the latter's blockbuster cholesterol-lowering drug Lipitor (atorvastatin) calling it a "very positive" development for the Indian drug maker